By Euro Weekly News Media • 22 July 2015 • 14:44
SCIENTISTS believe they have made an important breakthrough in developing treatments for Alzheimer’s disease. Results of trials on a new drug suggest it can slow the pace of the condition’s progress.Information released by the drug company Eli Lilly points to their drug, solanezumab, reducing the speed of mental decline by about a third, and it seems the drug may be able to keep brain cells killed by the condition alive for longer.The scientific community has extended a cautious welcome to the news, presented at an American conference, although data is still limited. Significant to the research was the stage at which the drug was given, with best effects registered in those who received the treatment early.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don't already have one. Review our
Share your story with us by emailing email@example.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews
Download our media pack in either English or Spanish.